[go: up one dir, main page]

FI892948A7 - Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi

Info

Publication number
FI892948A7
FI892948A7 FI892948A FI892948A FI892948A7 FI 892948 A7 FI892948 A7 FI 892948A7 FI 892948 A FI892948 A FI 892948A FI 892948 A FI892948 A FI 892948A FI 892948 A7 FI892948 A7 FI 892948A7
Authority
FI
Finland
Prior art keywords
therapeutically useful
chroman derivatives
preparing therapeutically
preparing
chroman
Prior art date
Application number
FI892948A
Other languages
English (en)
Swedish (sv)
Other versions
FI92824B (fi
FI92824C (fi
FI892948A0 (fi
Inventor
Guenther Haeusler
Rolf Gericke
Hanns Wurziger
Manfred Baumgarth
Ingeborg Lues
Rolf Bergmann
Peyer Jacques De
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3820506A external-priority patent/DE3820506A1/de
Priority claimed from DE3835011A external-priority patent/DE3835011A1/de
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of FI892948A0 publication Critical patent/FI892948A0/fi
Publication of FI892948A7 publication Critical patent/FI892948A7/fi
Publication of FI92824B publication Critical patent/FI92824B/fi
Application granted granted Critical
Publication of FI92824C publication Critical patent/FI92824C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)
  • Pyrane Compounds (AREA)
FI892948A 1988-06-16 1989-06-15 Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi FI92824C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3820506 1988-06-16
DE3820506A DE3820506A1 (de) 1988-06-16 1988-06-16 -n-heterocyclisch substituierte chromanderivate und ihre verwendung als arzneimittel
DE3835011A DE3835011A1 (de) 1988-10-14 1988-10-14 Chromanderivate
DE3835011 1988-10-14

Publications (4)

Publication Number Publication Date
FI892948A0 FI892948A0 (fi) 1989-06-15
FI892948A7 true FI892948A7 (fi) 1989-12-17
FI92824B FI92824B (fi) 1994-09-30
FI92824C FI92824C (fi) 1995-01-10

Family

ID=25869185

Family Applications (1)

Application Number Title Priority Date Filing Date
FI892948A FI92824C (fi) 1988-06-16 1989-06-15 Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi

Country Status (11)

Country Link
EP (1) EP0346724A1 (fi)
JP (1) JPH0240375A (fi)
KR (1) KR910000711A (fi)
AU (1) AU626549B2 (fi)
DK (1) DK296789A (fi)
FI (1) FI92824C (fi)
HU (1) HUT56096A (fi)
IL (1) IL90613A0 (fi)
NO (1) NO174391C (fi)
NZ (1) NZ229540A (fi)
PT (1) PT90864B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
FR2621587B1 (fr) * 1987-10-12 1990-02-09 Sanofi Sa Derives du dimethyl-2,2 chromene, procede pour leur preparation et composition pharmaceutiques les contenant
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
DE3918041A1 (de) * 1989-06-02 1990-12-06 Merck Patent Gmbh Chromanderivate
GB8924376D0 (en) * 1989-10-30 1989-12-20 Beecham Group Plc Novel compounds
EP0430621A3 (en) * 1989-11-29 1992-03-04 Beecham Group P.L.C. Process for the preparation of chiral 3,4-epoxy benzopyrans
JP2575226B2 (ja) * 1990-05-11 1997-01-22 吉富製薬株式会社 光学活性な3,4−ジヒドロ−3,4−エポキシ−2h−1ベンゾピラン化合物の製造法およびその合成中間体
TW257762B (fi) * 1991-06-14 1995-09-21 Nippon Chemicals Pharmaceutical Co Ltd
FI943489L (fi) * 1992-11-25 1994-09-22 Sandoz Ltd 2,2-dialkyyli- ja 2,2-dialkyyli-3,4-dihydro-3-hydroksi-2H-1-bentsopyraaneja
RU2104277C1 (ru) * 1992-11-25 1998-02-10 Сандос Лтд. 2-2-диалкил- или транс-2,2-диалкил-3,4-дигидро-3-гидрокси-6-(пиридин-4-ил)-2н-1-бензопиран
WO1994012493A1 (en) * 1992-11-25 1994-06-09 Sandoz, Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2h-1-benzopyr ans, their use as pharmaceuticals
IL108841A0 (en) * 1993-03-10 1994-06-24 Pfizer Res & Dev Benzopyrans
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
US5574049A (en) * 1994-07-22 1996-11-12 Sandoz Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans
JP2007000772A (ja) * 2005-06-23 2007-01-11 Casio Electronics Co Ltd 二重マイクロカプセル、その製造方法及びマイクロカプセルの表面処理方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE23718T1 (de) * 1981-09-25 1986-12-15 Beecham Group Plc Benzopyran-verbindungen mit pharmazeutischer wirkung.
EP0107423B1 (en) * 1982-10-19 1986-07-23 Beecham Group Plc Novel chromans and chromenes
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
DE3726261A1 (de) * 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate
CH674984A5 (fi) * 1987-05-16 1990-08-15 Sandoz Ag
FR2621587B1 (fr) * 1987-10-12 1990-02-09 Sanofi Sa Derives du dimethyl-2,2 chromene, procede pour leur preparation et composition pharmaceutiques les contenant
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives

Also Published As

Publication number Publication date
EP0346724A1 (de) 1989-12-20
FI92824B (fi) 1994-09-30
NO892494L (no) 1989-12-18
IL90613A0 (en) 1990-01-18
PT90864A (pt) 1989-12-29
NO174391C (no) 1994-04-27
FI92824C (fi) 1995-01-10
NZ229540A (en) 1991-03-26
DK296789A (da) 1989-12-17
AU3644089A (en) 1989-12-21
KR910000711A (ko) 1991-01-30
AU626549B2 (en) 1992-08-06
NO174391B (no) 1994-01-17
JPH0240375A (ja) 1990-02-09
DK296789D0 (da) 1989-06-15
PT90864B (pt) 1994-11-30
FI892948A0 (fi) 1989-06-15
HUT56096A (en) 1991-07-29
NO892494D0 (no) 1989-06-15

Similar Documents

Publication Publication Date Title
FI892182A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI890282L (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI905941A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
FI885409A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyridatsiiniamiinijohdannaisten valmistamiseksi
FI894217L (fi) 1-adamantaanijohdannaisten valmistusmenetelmä
FI881180L (fi) Menetelmä terapeuttisesti käytettävien tetrahydronaftaleenijohdannaisten valmistamiseksi
FI890842A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten stilbeenijohdannaisten valmistamiseksi
FI892850L (fi) Menetelmä uusien hepariinijohdannaisten valmistamiseksi
FI893433A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
FI893361L (fi) Menetelmä ACAT-inhiboivien kinoliinijohdannaisten valmistamiseksi
BG49939A3 (bg) Метод за получаване на 2-анилино-пиримидинови производни
FI891700L (fi) Menetelmä beta-laktaamijohdannaisten valmistamiseksi
FI891711L (fi) Menetelmä diorganodialkoksisilaanien valmistamiseksi
FI890283A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 25-hydroksi-vitamiinin D-johdannaisten valmistamiseksi
FI894803L (fi) Menetelmä terapeuttisesti käyttökelpoisten kinolinonijohdannaisten valmistamiseksi
FI892948A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI884910A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi
FI893701L (fi) Menetelmä antipsykoottisten 3-piperatsinyylibentsatsolijohdannaisten valmistamiseksi
FI890257A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi
FI893003L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI881525A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten N-aryylipiperatsiiniasetamidijohdannaisten valmistamiseksi
FI885560A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi
FI906203A7 (fi) Glyserolijohdosten valmistusmenetelmä
FI891362A7 (fi) Menetelmä uusien alkanofenonien valmistamiseksi
FI892420A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminoetanolijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUN